2009
DOI: 10.1590/s0004-27492009000300026
|View full text |Cite
|
Sign up to set email alerts
|

Ativador do plasminogênio tecidual e gás intravítreo no tratamento da síndrome de Terson: relato de caso

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…78 Use of intravitreal of tPA and sulfur hexafluoride in the management of Terson syndrome has been reported in 1 case. 79 The authors observed resorption of subretinal hemorrhage and improvement in visual acuity 1 week after the injection. 79 Nd:YAG Laser Nd:YAG laser can disrupt and drain preretinal hemorrhage in both children and adults with Terson syndrome.…”
Section: Tissue Plasminogen Activator (Tpa)mentioning
confidence: 94%
See 3 more Smart Citations
“…78 Use of intravitreal of tPA and sulfur hexafluoride in the management of Terson syndrome has been reported in 1 case. 79 The authors observed resorption of subretinal hemorrhage and improvement in visual acuity 1 week after the injection. 79 Nd:YAG Laser Nd:YAG laser can disrupt and drain preretinal hemorrhage in both children and adults with Terson syndrome.…”
Section: Tissue Plasminogen Activator (Tpa)mentioning
confidence: 94%
“…79 The authors observed resorption of subretinal hemorrhage and improvement in visual acuity 1 week after the injection. 79 Nd:YAG Laser Nd:YAG laser can disrupt and drain preretinal hemorrhage in both children and adults with Terson syndrome. [80][81][82] A laser beam is used to break the posterior hyaloid, allowing blood to enter the vitreous.…”
Section: Tissue Plasminogen Activator (Tpa)mentioning
confidence: 94%
See 2 more Smart Citations